[Essential thrombocythemia. Therapy with interferon alfa].
A clinical case of essential thrombocythaemia is presented to demonstrate good therapeutic response to subcutaneous Alpha-2b Interferon in a dosage of 3 x 10(6) units, three times a week. Based on this case and on a literature research we propose that Alpha-2b Interferon is a legitimate alternative to alkylating agents or radioactive phosphorus (32P), showing identical efficacy and less Leukemogen effect.
Lebre
L
L
Serviço de Medicina Interna, Hospital Sa. Cruz, Carnaxide.
Sousa
A
A
Sampaio
J
J
Novais
L
L
Júnior
E
E
Coelho
R
R
Simões
J
J
D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D008875:Middle Aged; D013920:Thrombocythemia, Essential / Q000628:therapy*
D016898:Interferon-alpha
Trombocitemia essencial. Terapêutica com alfa interferão.